Total Nutraceutical Solutions announces symbol change

In November, TNS announced that it would seek shareholder approval at its upcoming annual stockholders meeting to change its name to Entia Biosciences (Entia) and form a new subsidiary called Total Nutraceutical Solutions that will continue to manufacture and market health and wellness products to consumers. Entia will focus on the institutional dietary supplementation market with its ErgoD2 formulations, an optimised blend of the two powerful antioxidants Ergothioneine and Ergocalciferol (vitamin D2).

ErgoD2 is now being studied by Massachusetts General Hospital to assess its efficacy as a potential dietary therapy or palliative therapy for Parkinson's disease patients. Entia intends to announce additional collaborative research studies and clinical trials in the coming months that will address other potential applications for the company's proprietary food-based technology and products. Commenting on this change, Dr. Marvin Hausman, CEO of TNS stated, "The market for our Ergo-based products is significant and we feel that using ERGO as our stock symbol will help to reinforce the brand and Entia's corporate identity as we move forward."